Table 3.
Tissues |
Days post-infection |
||||
---|---|---|---|---|---|
3 | 6 | 9 | 12 | ||
Brain |
Control |
- |
- |
- |
- |
Infected |
1/3+ |
3/3++ |
3/3# |
3/3++ |
|
Heart |
Control |
- |
- |
- |
- |
Infected |
- |
- |
- |
- |
|
Lung |
Control |
- |
- |
- |
- |
Infected |
- |
- |
- |
- |
|
Liver |
Control |
- |
- |
- |
- |
Infected |
- |
- |
1/3++, 2/3# |
- |
|
Spleen |
Control |
- |
- |
- |
- |
Infected |
1/3+ |
3/3+ |
3/3++ |
1/3+ |
|
Kidney | Control |
- |
- |
- |
- |
Infected | - | - | 2/3++, 1/3# | - |
-, none; +, 1–3 focal inflammatory infiltrates, perivascular cuffing and microglial hyperplasia per high power field (HPF); ++, lesions covering 25% of a HPF; #, lesions covering >75% of a HPF.